BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35643867)

  • 1. Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence.
    Misund K; Hofste Op Bruinink D; Coward E; Hoogenboezem RM; Rustad EH; Sanders MA; Rye M; Sponaas AM; van der Holt B; Zweegman S; Hovig E; Meza-Zepeda LA; Sundan A; Myklebost O; Sonneveld P; Waage A
    Leukemia; 2022 Jul; 36(7):1887-1897. PubMed ID: 35643867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing.
    Gralewski JH; Post GR; van Rhee F; Yuan Y
    Diagn Pathol; 2018 Feb; 13(1):15. PubMed ID: 29463311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Impact of Genomic Complexity on the Transcriptome of Multiple Myeloma.
    Ziccheddu B; Da Vià MC; Lionetti M; Maeda A; Morlupi S; Dugo M; Todoerti K; Oliva S; D'Agostino M; Corradini P; Landgren O; Iorio F; Pettine L; Pompa A; Manzoni M; Baldini L; Neri A; Maura F; Bolli N
    Clin Cancer Res; 2021 Dec; 27(23):6479-6490. PubMed ID: 34526359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides.
    Egan JB; Shi CX; Tembe W; Christoforides A; Kurdoglu A; Sinari S; Middha S; Asmann Y; Schmidt J; Braggio E; Keats JJ; Fonseca R; Bergsagel PL; Craig DW; Carpten JD; Stewart AK
    Blood; 2012 Aug; 120(5):1060-6. PubMed ID: 22529291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MMRFBiolinks: an R-package for integrating and analyzing MMRF-CoMMpass data.
    Settino M; Cannataro M
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33821961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic complexity of multiple myeloma and its clinical implications.
    Manier S; Salem KZ; Park J; Landau DA; Getz G; Ghobrial IM
    Nat Rev Clin Oncol; 2017 Feb; 14(2):100-113. PubMed ID: 27531699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hierarchy of mono- and biallelic
    Munawar U; Rasche L; Müller N; Vogt C; Da-Via M; Haertle L; Arampatzi P; Dietrich S; Roth M; Garitano-Trojaola A; Steinhardt MJ; Strifler S; Gallardo M; Martinez-Lopez J; Bargou RC; Heckel T; Einsele H; Stühmer T; Kortüm KM; Barrio S
    Blood; 2019 Sep; 134(10):836-840. PubMed ID: 31340981
    [No Abstract]   [Full Text] [Related]  

  • 8. The mutagenic impact of melphalan in multiple myeloma.
    Maura F; Weinhold N; Diamond B; Kazandjian D; Rasche L; Morgan G; Landgren O
    Leukemia; 2021 Aug; 35(8):2145-2150. PubMed ID: 34012133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.
    Laganà A; Perumal D; Melnekoff D; Readhead B; Kidd BA; Leshchenko V; Kuo PY; Keats J; DeRome M; Yesil J; Auclair D; Lonial S; Chari A; Cho HJ; Barlogie B; Jagannath S; Dudley JT; Parekh S
    Leukemia; 2018 Jan; 32(1):120-130. PubMed ID: 28642592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal Evolution in Multiple Myeloma.
    Fakhri B; Vij R
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S130-4. PubMed ID: 27521309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chromosomal abnormalities and clonal evolution in multiple myeloma].
    Ishida T
    Rinsho Ketsueki; 2014 Oct; 55(10):2036-45. PubMed ID: 25297769
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple myeloma clonal evolution in homogeneously treated patients.
    Corre J; Cleynen A; Robiou du Pont S; Buisson L; Bolli N; Attal M; Munshi N; Avet-Loiseau H
    Leukemia; 2018 Dec; 32(12):2636-2647. PubMed ID: 29895955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Cytogenetic Analysis of Chromosome 8 Aberrations in Patients With Multiple Myeloma Examined in 2 Different Stages, at Diagnosis and at Progression/Relapse.
    Mlynarcikova M; Balcarkova J; Mickova P; Scudla V; Pika T; Bacovsky J; Minarik J; Janousova E; Jarosova M
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):358-65. PubMed ID: 27052024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of clonal evolution in multiple myeloma.
    Furukawa Y; Kikuchi J
    Int J Hematol; 2020 Apr; 111(4):496-511. PubMed ID: 32026210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.
    Weinhold N; Ashby C; Rasche L; Chavan SS; Stein C; Stephens OW; Tytarenko R; Bauer MA; Meissner T; Deshpande S; Patel PH; Buzder T; Molnar G; Peterson EA; van Rhee F; Zangari M; Thanendrarajan S; Schinke C; Tian E; Epstein J; Barlogie B; Davies FE; Heuck CJ; Walker BA; Morgan GJ
    Blood; 2016 Sep; 128(13):1735-44. PubMed ID: 27516441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis.
    Yang Q; Li K; Li X; Liu J
    Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167
    [No Abstract]   [Full Text] [Related]  

  • 17. Clonal competition with alternating dominance in multiple myeloma.
    Keats JJ; Chesi M; Egan JB; Garbitt VM; Palmer SE; Braggio E; Van Wier S; Blackburn PR; Baker AS; Dispenzieri A; Kumar S; Rajkumar SV; Carpten JD; Barrett M; Fonseca R; Stewart AK; Bergsagel PL
    Blood; 2012 Aug; 120(5):1067-76. PubMed ID: 22498740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of changes in subclonal architecture with progression in the MMRF CoMMpass study.
    Kaur G; Jena L; Gupta R; Farswan A; Gupta A; Sriram K
    Transl Oncol; 2022 Sep; 23():101472. PubMed ID: 35777247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-omics analysis of multiple myeloma patients with differential response to first-line treatment.
    Zheng B; Yi K; Zhang Y; Pang T; Zhou J; He J; Lan H; Xian H; Li R
    Clin Exp Med; 2023 Nov; 23(7):3833-3846. PubMed ID: 37515690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance.
    Paiva B; Corchete LA; Vidriales MB; Puig N; Maiso P; Rodriguez I; Alignani D; Burgos L; Sanchez ML; Barcena P; Echeveste MA; Hernandez MT; García-Sanz R; Ocio EM; Oriol A; Gironella M; Palomera L; De Arriba F; Gonzalez Y; Johnson SK; Epstein J; Barlogie B; Lahuerta JJ; Blade J; Orfao A; Mateos MV; San Miguel JF;
    Blood; 2016 Apr; 127(15):1896-906. PubMed ID: 26755711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.